|
STK17B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.41700000003231E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.69469999997418E-06 |
| Normal-vs-Stage2 |
3.636100E-03 |
| Normal-vs-Stage3 |
6.35339999999207E-05 |
| Normal-vs-Stage4 |
3.72160000000621E-05 |
| Stage1-vs-Stage2 |
7.866600E-01 |
| Stage1-vs-Stage3 |
6.330000E-01 |
| Stage1-vs-Stage4 |
4.084000E-01 |
| Stage2-vs-Stage3 |
9.701800E-01 |
| Stage2-vs-Stage4 |
8.115600E-01 |
| Stage3-vs-Stage4 |
7.878400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.37810000042793E-07 |
| Normal-vs-AfricanAmerican |
1.183630E-01 |
| Normal-vs-Asian |
9.305600E-02 |
| Caucasian-vs-AfricanAmerican |
1.095800E-02 |
| Caucasian-vs-Asian |
9.012600E-01 |
| AfricanAmerican-vs-Asian |
3.651400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.01990000000995E-06 |
| Normal-vs-Female |
2.798800E-04 |
| Male-vs-Female |
1.364240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.184400E-03 |
| Normal-vs-Age(41-60Yrs) |
2.22319999998444E-06 |
| Normal-vs-Age(61-80Yrs) |
3.56710000000149E-05 |
| Normal-vs-Age(81-100Yrs) |
3.008200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.579200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.961400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.074050E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.326200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.511910E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.922000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.009700E-02 |
| Normal-vs-Grade 2 |
1.59793999999769E-05 |
| Normal-vs-Grade 3 |
4.25179999996583E-06 |
| Normal-vs-Grade 4 |
2.31299999997603E-06 |
| Grade 1-vs-Grade 2 |
9.607200E-01 |
| Grade 1-vs-Grade 3 |
7.080200E-01 |
| Grade 1-vs-Grade 4 |
5.285800E-01 |
| Grade 2-vs-Grade 3 |
4.634800E-01 |
| Grade 2-vs-Grade 4 |
1.544980E-01 |
| Grade 3-vs-Grade 4 |
4.847600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.43599999999455E-05 |
| Normal-vs-ccB subtype |
6.03819999556165E-08 |
| ccA subtype-vs-ccB subtype |
2.031600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51036999999077E-05 |
| Normal-vs-N1 |
8.191100E-04 |
| N0-vs-N1 |
3.108400E-01 |
|
|
